Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue
May 1, 2026 6:37 AM EDTModerna (NASDAQ: MRNA) reported Q1 EPS of ($3.40), $1.38 worse than the analyst estimate of ($2.02). Revenue for the quarter came in at $389 million versus the consensus estimate of $251.76 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
... More